title: Conservative management of esophageal perforation following obesity surgery.
abstract: BACKGROUND
  Laparoscopic adjustable silicone gastric banding (LASGB) is one of the several surgical techniques for treating patients with morbid obesity. Erosion and perforation in the gastric chamber caused by LASGB are rare complications that have already been described. There have not yet been any reports of perforation of the middle esophagus during this procedure.
  
  
  METHODS
  The authors describe the case of a patient who presented the complication of very extensive perforation of the middle third of the esophagus following LASGB. This was successfully managed using conservative treatment.
authors.affiliation: Hospital Israelita Albert Einstein, São Paulo, Brazil. jcelso@uol.com.br
authors.forename: José Celso
authors.initials: JC
authors.lastname: Ardengh
authors.forename: Carlos Eduardo
authors.initials: CE
authors.lastname: Domene
authors.forename: Loana Heuko
authors.initials: LH
authors.lastname: Valiati
authors.forename: Alexander Charles
authors.initials: AC
authors.lastname: Morrell
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D004750:Enteral Nutrition; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D004939:Esophageal Perforation / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D015391:Gastroplasty / Q000009:adverse effects*; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D010535:Laparoscopy / Q000009:adverse effects*; D008795:Metronidazole / Q000627:therapeutic use; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D009853:Omeprazole / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D008795:Metronidazole; D002443:Ceftriaxone; D009853:Omeprazole